Tengion

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Terminated	A Phase 1, Open-label Safety Study of NKA in Patients With Type 2 Diabetes Chronic Kidney Disease	Phase 1	2013-12-01
Terminated	Study of an Autologous Neo-Kidney Augment in Patients With Chronic Kidney Disease Chronic Kidney Disease	Phase 1	2013-04-01
Completed	Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit Bladder Cancer	Phase 1	2010-03-01
Completed	Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Bladder Disease	—	2008-02-01
Withdrawn	Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence Overactive Bladder	Phase 2	2008-01-01
Completed	Study to Obtain Full Thickness Bladder Tissue From Subjects Undergoing Cystectomy Surgery Cystectomy	—	2007-08-01
Terminated	Study of Autologous Neo-Bladder Construct in Subjects With Neurogenic Bladder Following Spinal Cord Injury Neurogenic Bladder	Phase 2	2007-07-01
Terminated	Augmentation Cystoplasty Using an Autologous Neo-Bladder Neurogenic Bladder	Phase 2	2006-12-01